Peer Review History

Original SubmissionJune 27, 2024
Decision Letter - Kahsu Gebrekidan, Editor

PONE-D-24-23124Insulin Therapy Adherence and its Associated Factors among Diabetic Patients in a Ghanaian Primary Care HospitalPLOS ONE

Dear Dr. Sefah,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kahsu Gebrekidan, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

Thank you for your submission. Please note the following comments and suggestions

Abstract

- Background - please introduce a sentence to provide an insight into the problem before stating the last sentence on the purpose of the study.

Introduction

L93, it is important to insert the year of reference instead of "currently".

Is there any reason for prevalent in some specific regions etc?.

There is a need to strengthen the novelty of the study.

It is suggested that authors conduct a literature review on insulin therapy adherence. Please insert a section on that.

Method

Does the researchers have an idea of the study total population size before the adopted sample size?.

Discussion

There is a need to explore through the results, the impact of lifestyle and status on the study focus. Also, in the introduction, Authors mentioned the disparate records from the different regions in Ghana, does the study explore this aspect?

More can be achieved from the collected data.

Please create a section for the implication of the study.

Conclusion

Kindly review and enhance this to provide a robust Conclusion to the study.

Please review the manuscript for grammatical errors.

Reviewer #2: - The authors provide a good argument for the survey. The review of the literature is adequate, however I disagree that Insulin therapy is solely responsible for the outcomes in patients with diabetes mellitus (line 106 -108).

- The aim of the study is clear

- The target population is well defined

- The inclusion criteria is well defined

- The authors provide a clear description of the study processes, the data collection instrument and the statistical instruments used in the data analysis.

- The results are presented clearly in accurate tables

- The discussion is adequate but the authors should please look at the reviewer comments made on lines 263, 293-296, 303 - 311. The authors show a clear understanding of the limitations of the study method and processes

- The concluding statement is adequate. The recommendations made are reasonable based on the findings.

- The authors should please make minor corrections to the references high lighted. 10,11 and 34,35.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Reviewed - PONE-D-24-23124.pdf
Revision 1

REVIEWERS’ COMMENTS AND AUTHORS’ RESPONSES

Insulin Therapy Adherence and its Associated Factors among Diabetic Patients in a Ghanaian Primary Care Hospital

Reviewer #1: Dear Authors,

Thank you for your submission. Please note the following comments and suggestions

Abstract- Background - please introduce a sentence to provide an insight into the problem before stating the last sentence on the purpose of the study.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this. We have now added a statement defining the problem to the background section of the abstract

Introduction

L93, it is important to insert the year of reference instead of "currently".

Is there any reason for prevalent in some specific regions etc?.

There is a need to strengthen the novelty of the study.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this suggestion. We have now added the year of reference and additional details to strengthen the novelty and relevance of the study.

It is suggested that authors conduct a literature review on insulin therapy adherence. Please insert a section on that.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this. We have now added more details to show literature review conducted on the subject matter (line 102 to 106).

Method

Does the researchers have an idea of the study total population size before the adopted sample size?.

AUTHOR RESPONSE AND ACTION TAKEN: We based the calculation of our sample size on the average monthly outpatient attendance of 200 giving us a total of 600 patients to be expected at the clinic over the 3 months’ duration of data collection. We have now updated that section of the method to bring clarity to our estimation (line 152 to 155)

Discussion

There is a need to explore through the results, the impact of lifestyle and status on the study focus. Also, in the introduction, Authors mentioned the disparate records from the different regions in Ghana, does the study explore this aspect?

More can be achieved from the collected data.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this comment. Our study was done in just one hospital which provides service to patients living just around the hospital and so we could not explore the different prevalence levels at different regions and settings. We have indicated this as a limitation to our study (line303 to 305).

Please create a section for the implication of the study.

AUTHOR RESPONSE AND ACTION TAKEN:

Conclusion

Kindly review and enhance this to provide a robust Conclusion to the study.

AUTHOR RESPONSE AND ACTION TAKEN:

Please review the manuscript for grammatical errors.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this. We have now updated the manuscript by correcting identified grammatical errors.

Reviewer #2: - The authors provide a good argument for the survey. The review of the literature is adequate, however I disagree that Insulin therapy is solely responsible for the outcomes in patients with diabetes mellitus (line 106 -108).

- The aim of the study is clear

- The target population is well defined

- The inclusion criteria is well defined

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for your comments.

- The authors provide a clear description of the study processes, the data collection instrument and the statistical instruments used in the data analysis.

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this.

- The results are presented clearly in accurate tables

AUTHOR RESPONSE AND ACTION TAKEN: We are very grateful for this comment.

- The discussion is adequate but the authors should please look at the reviewer comments made on lines 263, 293-296, 303 - 311. The authors show a clear understanding of the limitations of the study method and processes

AUTHOR RESPONSE AND ACTION TAKEN: Thank you for this. We have now updated the manuscript based on the comments made concerning those portions of the paper to more details on the relevance of our findings and the limitations in our study

- The concluding statement is adequate. The recommendations made are reasonable based on the findings.

AUTHOR RESPONSE AND ACTION TAKEN: We are very grateful for this.

- The authors should please make minor corrections to the references high lighted. 10,11 and 34,35.

AUTHOR RESPONSE AND ACTION TAKEN: We have now corrected the errors in the references identified. Thank you.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Kahsu Gebrekidan, Editor

PONE-D-24-23124R1Insulin Therapy Adherence and its Associated Factors among Diabetic Patients in a Ghanaian Primary Care HospitalPLOS ONE

Dear Dr. Sefah,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kahsu Gebrekidan, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The revision has been completed to the satisfaction of this reviewer. I have no further comments to add.

Reviewer #3: There were omission in line 51- it should be Kwame Nkrumah University of Technology, this is repeated in line 140. In line 46, the authors should be clear on which patients are place on insulin by stating all types is not clear. the sampling utilised in the study was convenience sampling, author was silent on how this was done at the facility and how many days were used to recruit participants for the study. The abstract of the study needs review especially on all types of diabetes. The inclusion criteria included persons older than 18 years however, in the results section, the age range was between 16-20, author should address the difference in age. It is not clear if all the type 2 diabetes were on the combine medication of insulin and oral glycemic agents.

the references had a different font.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

AUTHORS RESPONSE TO REVIEWER COMMENTS

REVIEWER 2

Comment: The authors have given a clear description of the processes for the sampling and administering of the data collection tool.

Authors response: We are grateful for this comment.

Comment: The data analysis used had adequate statistical instruments to test the associations between dependent and independent variables.

Authors response: We are grateful for this comment.

Comment: The presentation of the results are clear and precise. The tables are accurate

Authors response: Thank you for this comment.

Comment: The authors need to review the document for minor errors such as this - level of adherence OR adherence level...

Authors response: Thank you for this correction. The document has now been updated by removing the error “level of”.

Comment: This argument is unclear as the authors state in the opening statement to the paragraph that the employed were less likely to be non-adherent. The mode of payment may be an entirely different argument. What did the authors mean by 'mode of payment' in the MARS-5 tool that was used?

Authors response: Thank you for comment. The mode of payment was not part of the MARS-5 question but was added to assess how cash payment and/ or insurance has an influence on adherence. We believe that cash payment for insulin and employment status are all economic factors that may influence adherence level. We have added extra details in our manuscript to explain this (Lines 308-309).

Comment: Another limitation of this study is the fact that authors did not look at the subjective aspects of control that may limit the level of control in patients. All the arguments are solely focused on adherence to insulin therapy excluding the other aspects of diabetes care that could serve as confounders to the findings especially relating to control of serum glucose levels.

Authors response: Thank you for this input. We have now included this as an important confounding factor that was not assessed (Line 325-327).

Comment The concluding statement is adequate as it focuses on the findings related to the aim of the study.

Authors response: We are grateful for this comment.

Comment: Please review this reference for the appropriate Vancouver style. It also looks like two references put together in error.

Authors response: Thank you for this correction. The errors with references 10 and 11 are now corrected (Lines 387-390).

Comments: Authors should please correct the errors in the reference list.

Authors’ response: Thank you for this. The references have been updated to Vancouver style.

Comment Please make the necessary corrections to this reference. Please reference Vancouver style.

Authors response: Thank you for this correction. The errors with reference numbers 34 and 35 are now corrected (Line 450 – 452).

REVIEWER 3

Comment: There were omissions in line 51- it should be Kwame Nkrumah University of Technology, this is repeated in line 140.

Authors response: Thank you for this. Corrections have now been made to this update. (Lines 36 and 127)

Comment: In line 46, the authors should be clear on which patients are place on insulin by stating all types is not clear.

Authors response: Thank you for this. The error is now corrected in line 147.

Comment: The sampling utilized in the study was convenience sampling, author was silent on how this was done at the facility and how many days were used to recruit participants for the study.

Authors response: We have now on how patients were recruited using the convenience sampling technique (line 146-147). The interview duration is captured in the manuscript at line 164-165

Comment: The abstract of the study needs review especially on all types of diabetes.

Authors response: Thank you for this correction. We have updated the manuscript (Line 30)

Comment: The inclusion criteria included persons older than 18 years however, in the results section, the age range was between 16-20, author should address the difference in age.

Authors response: Thank you for this. We have now corrected the age range to 18-20 years.

Comment: It is not clear if all the type 2 diabetes were on the combine medication of insulin and oral glycemic agents.

Authors response: This is not so in our study. It is worthy to note that a significant number of the patients were on oral therapy (n=156) which is closer to the number of type 2 DM (n=159) in our study.

Comment: The references had a different font.

Authors response: Thank you for this. We have now formatted the references.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Kahsu Gebrekidan, Editor

Insulin Therapy Adherence and its Associated Factors among Diabetic Patients in a Ghanaian Primary Care Hospital

PONE-D-24-23124R2

Dear Dr. Israel,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kahsu Gebrekidan, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: Authors have addressed all the comments raised in the first review and I am satisfied with their responses

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Kahsu Gebrekidan, Editor

PONE-D-24-23124R2

PLOS ONE

Dear Dr. Sefah,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kahsu Gebrekidan

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .